Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Nihar R. Desai's publication output changed over time?
ScholarIQpublication output · 2012–2025
Output grew0% over the shown period — from 1 works in 2012 to 1 in 2025.
1
1
3
1
3
1
1
1
20122013201620182019202020212025
What are the most-cited papers on Nihar R. Desai?
ScholarIQmost cited works
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald, Philippe Gabríel Steg, Jaime A. Davidson, Boaz Hirshberg, Peter Öhman, Robert Frederich, Stephen D. Wiviott, Elaine Hoffman, Matthew A. Cavender, Jacob A. Udell, Nihar R. Desai, Ofri Mosenzon, Darren K. McGuire, Kausik K. Ray, Lawrence A. Leiter, Itamar Raz
New England Journal of Medicine. 20133,486 CitationsOPEN ACCESS
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
Robert P. Giugliano, Nihar R. Desai, Payal Kohli, William J. Rogers, Ransi Somaratne, Fannie Huang, Thomas Liu, Satishkumar Mohanavelu, Elaine Hoffman, Shannon T McDonald, Timothy E Abrahamsen, Scott M. Wasserman, Robert C. Scott, Marc S. Sabatine
The Lancet. 2012424 Citations
The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support
Amit P. Amin, John A. Spertus, Jeptha P. Curtis, Nihar R. Desai, Frederick A. Masoudi, Richard G. Bach, Christian McNeely, Firas Al-Badarin, John A. House, Hemant Kulkarni, Sunil V. Rao
Circulation. 2019417 CitationsOPEN ACCESS
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013
Joseph Salami, Haider J. Warraich, Javier Valero‐Elizondo, Erica S. Spatz, Nihar R. Desai, Jamal S. Rana, Salim S. Virani, Ron Blankstein, Amit Khera, Michael J. Blaha, Roger S. Blumenthal, Donald M. Lloyd‐Jones, Khurram Nasir
JAMA Cardiology. 2016380 Citations
Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
Sanket S. Dhruva, Joseph S. Ross, Bobak J. Mortazavi, Nathan C. Hurley, Harlan M. Krumholz, Jeptha P. Curtis, Alyssa Berkowitz, Frederick A. Masoudi, John C. Messenger, Craig S. Parzynski, Che Ngufor, Saket Girotra, Amit P. Amin, Nilay D. Shah, Nihar R. Desai
JAMA. 2020379 CitationsOPEN ACCESS
Related on ScholarIQ
Yale New Haven Hospital
Institution
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Paper
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
Paper
The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support
Paper
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013
Paper
Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
Paper